Special targeted therapy like endothelial growth factor receptor (EGFR) targeted therapy is
available for the treatment of advanced non-small cell lung cancer (NSCLC). Biodegradable …

Purpose Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer. Lipid–
polymer hybrid nanoparticles (LPNs) combine the advantages of both polymeric …

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality in
China. This study aimed to develop a hyaluronic acid (HA) decorated, pH sensitive lipid …

Purpose Lung cancer is the leading cause of cancer mortality worldwide. Drug resistance is
the major barrier for the treatment of non-small cell lung cancer (NSCLC). The aim of this …

The rate of lung cancer in tuberculosis (TB) patients is 7 to 30% higher than that in healthy
individuals. Conventional chemotherapy of lung cancer shows limited efficiency due to poor …

One approach to improve the targeted therapeutic efficiency of lung cancer is to deliver
drugs using nano-scaled systems. In this study, RGD peptide-modified, paclitaxel (PTX) …

Core–shell type lipid–polymer hybrid nanoparticles (CSLPHNPs) have emerged as a
multifunctional drug delivery platform. The delivery system combines mechanical …

Purpose Non-small cell lung cancer (NSCLC) therapy faces the barriers including drug
resistance. A transferrin-functionalized protein-lipid hybrid nanoparticle (PLHN) was …

The aim of the present study is to design a novel dual-ligand lipid based nanoparticle
system. It is conducted by a specific ligand and pH sensitive lipid conjugate. Docetaxel …

Context: Paclitaxel (PTX) and doxorubicin (DOX) are widely used for the combined
chemotherapy of solid tumors. However, free drug combination has lower antitumor …